Timothy J. Ley, et al., "5-Azacytidine Selectively Increases .gamma.-globin Synthesis in a Patient with .beta..sup.+ Thalassemia", New England Journal of Medicine, vol. 307:1469-1475 (Dec. 9, 1982). |
Michael B. Sporn, et al., "Chemoprevention of Cancer with Retinoids", Federation Proceedings, vol. 38:2528-2534 (Oct. 1979). |
Richard L. Momparler, et al., "Clinical Trial on 5-AZA-2'-Deoxycytidine in Patients with Acute Leukemia", Pharmac. Ther., vol. 30:277-286 (1985). |
Gary J. Kelloff, et al., "Chemoprevention Clinical Trials", Mutation Research, vol. 267:291-295 (1992). |
I. Bernard Weinstein, "Cancer Prevention: Recent Progress and Future Opportunities", Cancer Research, vol. 51:5080s-5085s (1991). |
Olli Simell, et al, "Waste Nitrogen Excretion Via Amino Acid Acylation: Benzoate and Phenylacetate in Lysinuric Protein Intolerance", Pediatr. Res., vol. 20:1117-1121 (1986). |
Neish, et al., "Phenylacetic Acid as a Potential Therapeutic Agent for the Treatment of Human Cancer", Experimentia, vol. 27:860-861 (1971). |
J.A. Stamatoyannopoulos, et al., "Therapeutic Approaches to Hemoglobin Switching in Treatment of Hemoglobinopathies", Annu. Rev. Med., vol. 43:497-521 (1992). |
Dvorit Samid, et al., "Selective Growth Arrest and Phenotypic Reversion of Prostate Cancer Cells In Vitro by NonToxic Pharmacological Concentrations of Phenylacetate", The Journal of Clinical Investigation, vol. 91:2288-2295 (1993). |
Dvorit Samid, et al., "Induction of Erythroid Differentiation and Fetal Hemoglobin Production in Human Leukemic Cells Treated with Phenylacetate", Journal of the Amiercan Society of Hematology, vol. 80:1576-1581 (1992). |
Dvorit Samid, et al., "Phenylacetate: A Novel Nontoxic Inducer of Tumor Cell Differentiation", Cancer Research, vol. 52:1988-1992 (1992). |
George J. Dover, et al., "Increased Fetal Hemoglobin in Patients Receiving Sodium 4-Phenylbutyrate", The New England Journal of Medicine, vol. 327:569-570 (1992). |
Burzynski, S.R. et al., Preclinical Studies on antineoplaston AS2-1 and Antineoplaston AS2-5, Drugs Exptl. Clin. Res., Supplemental 1, XII:11-16 (1986). |
Leary, Cancer Drug Also Helps in Treating Sickle Cell Anemia, Researchers Say, Atlanta Journal-Constitution, Thursday, Aug. 20, 1992. |
Smigel, K., "Non-toxic drug being tested to treat cancer and anemias (news)", J. Natl. Cancer Inst., 84(18):1398 (Sep. 16, 1992). |
Ross, Philip D. and Subramanian, S., Inhibition of sickle cell hemoglobin gelation by some aromatic compounds, Briochem. Biophys. Res. Commun., 77:1217-1223 (1977). |
Jones, G.L., Anti sickling effects of Betw Di Ethylaminoethyldiphenylpropyl acetate SFK-525-A, Pharmacologist, 20(3):204 (1978). |
Erhum, Wilson O., Acetonyl esters of hydroxybenzoic acids as potential antisickling agents, Niger. J. Pharm., 12:285-287 (1981). |
Abemayor, E. et al., Effects of retinoic acid on the in vivo growth of human neuroblastoma cells,Cancer Lett. (Netherlands), 70(1-2):15-24 (Jun. 15, 1993). |
Cinatl, J. et al., In vitro differentiation of human neuroblastoma cells induced by sodium phenylacetate, Cancer Lett. (Netherlands), 70(1-2):15-24 (Jun. 15, 1993). |
Gorski, G.K. et al., Synergistic inhibition of human rhabdomyosarcoma cells by sodium phenylacetate and tretinoin, In Vitro Cell. Dev. Biol., 29A:189-191 (Mar. 1993). |